— Know what they know.
Not Investment Advice
Also trades as: NTRB (NASDAQ) · $vol 0M

NTRBW NASDAQ

Nutriband Inc.
1W: +1.9% 1M: -44.2% 3M: -55.8% YTD: -67.1% 1Y: -73.9% 3Y: -71.3%
$0.51
-0.02 (-3.79%)
 
NASDAQ · Healthcare · Biotechnology · Alpha Radar Strong Sell · Power 36 · $38.1M mcap · 5M float · 0.017% daily turnover · Short 46% of daily vol
Smart Money Score
No convergence signal
Key Statistics
Market Cap$38.1M
52W Range0.4-2.99
Volume1
Avg Volume878
Beta1.94
Dividend
Analyst Ratings
No analyst coverage
Company Info
CEOGareth Sheridan
Employees3
SectorHealthcare
IndustryBiotechnology
IPO Date2021-10-01
121 South Orange Avenue
Orlando, FL 32801
US
407 377 6695
About Nutriband Inc.

Nutriband Inc. is a pharmaceutical company dedicated to advancing a diverse pipeline of transdermal drug products. Foremost among its developmental initiatives is an abuse-deterrent fentanyl transdermal system. This innovative patch aims to provide both healthcare providers and patients with an extended-release fentanyl solution for the effective management of chronic pain. Beyond its core transdermal portfolio, Nutriband Inc. also holds a licensing agreement with Rambam Med-Tech Ltd. for the development of RAMBAM Closed System Transfer Devices. Established in 2016, the company maintains its corporate headquarters in Orlando, Florida.

Recent Insider Trades

NameTypeSharesPriceDate
Sheridan Gareth 0 2025-01-31
Sheridan Gareth A-Award 29,333 $8.07 2025-01-29
Goodman Gerald A-Award 17,667 $7.34 2025-01-23
Goodman Gerald M-Exempt 87,500 $1.93 2024-06-06
Goodman Gerald X-InTheMoney 60,085 $1.93 2024-06-05

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms